Richard Chin | Chief Executive Officer |
Denise Bevers | President and Chief Operating Officer |
Wendy Wee | Chief Financial Officer |
Katja Buhrer | Vice President-Corporate Development-Investor Relations. |
Brandon Folkes | Cantor Fitzgerald |
David Westenberg | CL King |
Ben Haynor | Alliance Global Partners |
Andrew D'Silva | B. Riley FBR |
Brooks O'Neil | Lake Street Capital |
Swayampakula Ramakanth | H.C. Wainwright |
Ben Haynor | Alliance Global Partners |
Welcome to the Third Quarter 2018 Financial Results Conference Call and Webcast for Kindred Biosciences. [Operator Instructions] Please note that the remarks today will include forward-looking statements and that actual results could differ materially from those projected or implied in our forward-looking statements.
For a description of important factors that could cause actual results to differ, we refer you to the forward-looking statements in today's press release and the note on forward-looking statements in the company's SEC filings. It is now my pleasure to turn the call over to KindredBio's CEO, Richard Chin. Dr.